Technical Analysis for MBRX - Moleculin Biotech, Inc.

Grade Last Price % Change Price Change
grade D 1.32 -0.75% -0.01
MBRX closed down 0.75 percent on Friday, March 22, 2019, on 38 percent of normal volume.

Earnings due: Apr 3

*** please verify all earnings dates ***

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Up
See historical MBRX trend table...

Date Alert Name Type % Chg
Mar 22 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Mar 21 50 DMA Resistance Bearish -0.75%
Mar 21 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -0.75%
Mar 20 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -0.75%
Mar 20 Crossed Above 20 DMA Bullish -0.75%
Mar 20 MACD Bullish Signal Line Cross Bullish -0.75%
Mar 19 20 DMA Resistance Bearish 3.94%
Mar 19 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 3.94%
Mar 18 Narrow Range Bar Range Contraction 5.60%
Mar 18 NR7 Range Contraction 5.60%

Older signals for MBRX ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Moleculin Biotech, Inc., a preclinical and clinical-stage pharmaceutical company, focuses on the development of anti-cancer drug candidates. Its lead drug candidate is liposomal Annamycin, an anthracycline intended for the treatment of relapsed or refractory acute myeloid leukemia. The company also develops other drugs, including WP1066 Portfolio, a portfolio of small molecules targeting the modulation of transcription factors involved in cancer; and WP1122 Portfolio, a suite of molecules targeting the metabolic processes involved in cancer and glioblastoma. Moleculin Biotech, Inc. was founded in 2015 and is headquartered in Houston, Texas.
Medicine Cancer Pharmaceutical Oncology Chemotherapy Acute Myeloid Leukemia Antineoplastic Drugs Glioblastoma Refractory Acute Myeloid Leukemia
Is MBRX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 2.43
52 Week Low 0.93
Average Volume 175,707
200-Day Moving Average 1.4785
50-Day Moving Average 1.365
20-Day Moving Average 1.286
10-Day Moving Average 1.269
Average True Range 0.0789
ADX 22.49
+DI 17.2922
-DI 14.2534
Chandelier Exit (Long, 3 ATRs ) 1.1633
Chandelier Exit (Short, 3 ATRs ) 1.4167
Upper Bollinger Band 1.3803
Lower Bollinger Band 1.1917
Percent B (%b) 0.68
BandWidth 14.66563
MACD Line -0.0175
MACD Signal Line -0.0285
MACD Histogram 0.011
Fundamentals Value
Market Cap 26.74 Million
Num Shares 20.3 Million
EPS -0.47
Price-to-Earnings (P/E) Ratio -2.81
Price-to-Sales 0.00
Price-to-Book 1.59
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.41
Resistance 3 (R3) 1.41 1.38 1.40
Resistance 2 (R2) 1.38 1.36 1.38 1.39
Resistance 1 (R1) 1.35 1.34 1.34 1.35 1.38
Pivot Point 1.32 1.32 1.31 1.32 1.32
Support 1 (S1) 1.29 1.30 1.28 1.29 1.26
Support 2 (S2) 1.26 1.28 1.26 1.25
Support 3 (S3) 1.23 1.26 1.25
Support 4 (S4) 1.23